Drug Profile
Recombinant erythropoietin biosimilar - Elea
Alternative Names: Human recombinant erythropoietin - Elea; Pronivel; r-hu-EPO - EleaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Elea
- Class Antianaemics; Erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia